Latest news with #SKII
Malay Mail
17-07-2025
- Entertainment
- Malay Mail
Singapore's Biggest Beauty Sale Returns with $1 Deals, Rolex Prizes, and a BYD Electric Car Giveaway
Luxury beauty gift sets Labubu & Crybaby blind boxes Viral favourites featured by influencers Rolex Draws on 27 July & 2 August BYD Atto 3 Electric Car on 3 August (requires min. $500 spend in one receipt) Over 200 beauty, skincare, fragrance & haircare brands Exclusive event-only pricing — not available online or in stores Free entry to all lucky draws with every ticket $1 steals and up to 90% off luxury and trending products Goodie bags worth $388 for top 400 spenders each day Easy access via Expo MRT, fully air-conditioned venue Proven success — 100,000+ shoppers at past Beauty Fiestas SINGAPORE - Media OutReach Newswire - 17 July 2025 - Beauty Fiesta 2025 is set to dazzle beauty lovers once again with its most spectacular edition yet. Taking place at Singapore EXPO Hall 6A across two weekends (25–27 July and 1–3 August), the event promises over 6,000 beauty deals, exclusive daily drops from $1, and grand prize giveaways including a Rolex timepiece and a BYD Atto 3 electric more than 100,000 attendees in previous years, this year's Beauty Fiesta is poised to be the ultimate destination for luxury beauty steals and viral must-haves — all under one miss the Helena Rubinstein Re-Plasty Night Cream — now just $328 (U.P. $659), one of the lowest prices in Singapore for this luxury icon. Other steals include SK-II Facial Treatment Essence 230ml at $148, La Prairie Eye Complex 15ml at $89, Masks (5s) at $8, and Decorté Prime Latte Emulsion for only $ cult-favourites like NARS Air Matte Lip at $15 (U.P. $48), Lancôme Cushion Compact for $39, and Givenchy Prisme Libre Powder at $39 — luxe formulas at bargain lovers will find iconic scents like Jo Malone English Pear 100ml at $109, Armani Prive The Yulong at $168, and Burberry 100ml EDPs from $49. Even bigger steals include Elizabeth Arden 5th Avenue 75ml for just $19 and Issey Miyake 123ml at $ essentials like Olaplex LashBond Serum for $19, Aveda 1L Shampoo at $49, and Shu Uemura Cleansing Oils 450ml for $65 — perfect for self-care daily drops start at just $1 — revealed on-site only. Come early before they're Spend $300 or more and be among the first 400 shoppers each day to redeem a $388 goodie bag, packed with full-sized products from beloved beauty brands. While stocks ticket holders are automatically entered into the daily lucky draws, held three times per day. Prizes include:Grand Prizes:Winners need not be present to 25–27 July and 1–3 August 2025 (Friday to Sunday)Opening Hours: 10:00 AM to 9:30 PM dailyLocation: Singapore EXPO, Hall 6AAdmission: $10 per ticketBuy Tickets Now: Official Website: "This year's Beauty Fiesta isn't just about discounts — it's about celebrating self-expression, discovery, and the joy of beauty," said the organising team. "Whether you're a skincare devotee, fragrance collector, or simply love a great deal, this is the one event you won't want to miss."Hashtag: #Beureka The issuer is solely responsible for the content of this announcement.
Globe and Mail
23-06-2025
- Business
- Globe and Mail
Can Procter & Gamble's Pricing Power Keep Earnings Buoyant in 2025?
The Procter & Gamble Company 's PG pricing strength serves as a vital pillar of its overall business strategy, which looks to enrich consumer value, boost profits and retain a competitive edge. PG's value-based pricing approach across categories like laundry detergents enables it to reduce dependence on promotional discounts, alongside maintaining competitive pricing and sustaining market share. PG's pricing strategy extends beyond price hikes and controls, complemented by ongoing product innovations and launches that drive value and validate premium positioning. Procter & Gamble has innovations across all price tiers within the Fabric Care Tight, Oxy Boost and Power Pods. The company is focused on optimizing skincare pricing in China, complemented by super-premium innovations under the SK-II portfolio, which is aimed at expanding its market share in the region. In the recent past, the company has successfully navigated elevated commodity costs, supply-chain disruptions, inflationary headwinds and currency volatility by its strategic pricing and productivity measures, reaffirming its commitment to steady margin growth. PG's pricing power has also offered resilience in tough times, like the pandemic. The company's goal is to regain pre-pandemic productivity levels, with a target of accomplishing gross savings in the cost of goods sold of up to $1.5 billion, before tax. In third-quarter fiscal 2025, pricing rose 1% and aided organic sales and gross margin. Our model anticipates pricing gains of 0.6% each for the fourth quarter and fiscal 2025. This is likely to continue bolstering organic sales, which we anticipate growing 1.9% and 2%, respectively, for the fourth quarter and fiscal 2025. As Procter & Gamble has an extensive portfolio with diverse price points and pack sizes, it continues to evaluate consumer pricing in effective categories and markets to ensure competitiveness. The company targets pricing with innovation and is focused on implementing pricing actions, which are likely to drive sustained growth and profitability. PG's Competition in Pricing Dominance Colgate-Palmolive Company CL and The Clorox Company CLX are the major companies competing with Procter & Gamble in pricing strength. Colgate also leverages its pricing power to aid growth and offset external cost pressures. The company is benefiting from key pricing actions, coupled with its funding-the-growth program and other productivity moves, aimed at driving efficiency and expanding margins. It has revamped its innovation model, leveraged its global scale across price tiers, invested in marketing and reinforced operational capabilities, all to drive brand health and higher household penetration. In first-quarter 2025, Colgate's organic sales were driven by a 1.5% improvement in pricing. We expect the company to benefit from pricing of 2.5% in 2025. Colgate's competitive pricing moves across its premium oral and personal care products will continue to bolster brand strength and retain market share. Clorox also places strong emphasis on pricing. The company's strategic pricing and cost-saving measures have been boosting gross margin expansion in recent periods. Despite the sales decline in third-quarter fiscal 2025, the gross margin expanded 240 basis points year over year, marking the company's 10th consecutive quarter of margin expansion. Clorox's holistic margin-management efforts, constant product innovations and IGNITE strategy progress well. Clorox's multi-faceted pricing policy includes premium pricing for its core brands, with a focus on premiumization and value for consumers. Our model anticipates price/mix/other to grow 0.2% in fiscal 2025. PG's Price Performance, Valuation and Estimates Procter & Gamble's shares have lost around 3.8% year to date compared with the industry 's 1.8% dip. From a valuation standpoint, PG trades at a forward price-to-earnings ratio of 22.67X, compared with the industry's average of 20.19X. The Zacks Consensus Estimate for PG's fiscal 2025 and 2026 EPS indicates year-over-year growth of 2.9% and 3.6%, respectively. The company's EPS estimate for fiscal 2025 has been stable and that for fiscal 2026 has moved northward in the past 30 days. Procter & Gamble currently carries a Zacks Rank #4 (Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Procter & Gamble Company (The) (PG): Free Stock Analysis Report Colgate-Palmolive Company (CL): Free Stock Analysis Report The Clorox Company (CLX): Free Stock Analysis Report
Yahoo
25-04-2025
- Business
- Yahoo
Procter & Gamble Cuts Full-year Forecast Amid Tariffs and Weaker Demand, Signals Price Hikes
Procter & Gamble lowered its full-year forecast on the back of lower sales and sky-high tariffs on China. It also indicated that it would likely raise prices. The Cincinnati, Ohio-based consumer products group, which makes Pampers, Tide, Olay and SKII, among other brands, now expects sales for fiscal 2025 to be flat. It previously forecast growth of between 2 and 4 percent. More from WWD Melania Trump Chooses Dolce & Gabbana Trenchcoat for White House Departure for Pope's Funeral The 'Resilient Consumer' Is Now Just 'Coping' in Donald Trump's Trade War DEI Lives at Levi's: Less than 1% of Shares Voted to Ditch Diversity Programs Chief financial officer Andre Schulten said: 'Our approach in the face of this near-term volatility is to protect our investment in our long-term health of our brands, innovation and demand creation. We are adjusting our fiscal year guidance in accordance with this approach.' On tariffs, he told analysts that while China accounts for just over 10 percent of the group's imports, the size of the tariff rate makes the cost impact more substantial. At the beginning of the month, U.S. President Donald Trump unveiled sweeping punitive tariffs on around 60 countries, sending the markets into a tailspin. While he soon stepped back, authorizing a 90-day pause — 'and a substantially lowered reciprocal tariff during this period' of 10 percent, he upped import duties on China-made goods to as high as 145 percent. Beijing responded with 125 percent on U.S. goods. 'We'll be looking for every opportunity to mitigate the impacts, including sourcing flexibility and productivity improvements,' Schulten said. 'We also need to consider some level of consumer pricing in affected categories and markets.' For third quarter fiscal year 2025, net sales fell 2 percent to $19.8 billion versus the prior year. Analysts had penciled in $20.1 billion. Organic sales, which excludes the impacts of foreign exchange and acquisitions and divestitures, increased 1 percent versus the prior year. A breakdown on that headline sales number showed that beauty segment organic sales increased 2 percent versus a year ago. Within that, hair care sales were unchanged as increased pricing in Latin America and North America was offset by volume declines, primarily in Greater China. Skin care organic sales, meanwhile, declined low-single digits due to volume declines and unfavorable geographic mix. In the grooming segment, organic sales increased 3 percent versus year ago. On a geographical basis, organic sales in North America grew 1 percent, below the 4 percent growth trend over the last five quarters, driven by weaker consumer demand. Europe-focused market organic sales were up 1 percent, with the company singling out France as a 'significant headwind' with organic sales down in the high teens in the quarter versus a base period that grew 20 percent. Greater China organic sales declined 2 percent, which Schulten described as 'a modest step up on the path back to growth in the region.' Best of WWD The Best Makeup Looks in Golden Globes History A Look Back at Golden Globes Best Makeup on the Red Carpet, From Megan Fox to Sophia Loren [PHOTOS] The Best Hairstyles in Golden Globes History Sign in to access your portfolio
Yahoo
27-01-2025
- Business
- Yahoo
Is China Dragging Down This Dow Jones Dividend King Stock?
Procter & Gamble (NYSE: PG) is an ultra-reliable dividend-paying company. With a diverse and global portfolio spanning several daily use product categories and 68 years of consecutive dividend raises, P&G is a passive income powerhouse Dividend King that investors can rely on no matter what the company is doing. But that doesn't mean the Dow Jones Industrial Average (DJINDICES: ^DJI) component is firing on all cylinders. The company reported second-quarter fiscal 2025 results on Jan. 22. P&G returned to volume growth and reaffirmed its full-year fiscal guidance. What's more, P&G's results significantly improved in Greater China, with organic sales declining 3% compared to a 15% decline last quarter. P&G saw a pickup in consumption and travel retail out of China, with CFO Andre Scholten saying the company is "trending back toward growth in Greater China." Management discussed China at length on this earnings call. Here's what is working and not working in China, buyer behavior trends, how P&G is developing new products to reflect changing consumer preferences. Scholten said, "I want to be clear, I don't think China is out of the woods." In the first quarter of fiscal 2025, P&G saw flat overall volume, and negative volume growth in three of its five segments. While 85% of the business saw excellent 4.8% organic sales growth, Greater China, Asia, the Middle East, and Africa weighed heavily on the business, with a 7.5% decline in organic sales growth. This quarter marked noticeable improvement in Greater China. But the region continues to be weak, especially because P&G's beauty business is big in China. P&G CEO Jon Moeller elaborated during the recent earnings call: China beauty broadly has a higher presence in China than any of our other categories. And we're still not out of the woods, we'll use that expression again, on volume in China. So while sales were 3%, I believe volume was minus 6%. I feel comfortable that's going to continue to improve. But when you look at beauty volumes, you have to realize that China waiting, which in many periods has been a very positive thing, but now presents a challenge. To spur growth, P&G is changing how it does business in China and implementing product innovations. For example, the Olay product line has historically focused on tone benefits in China, but P&G sees the market shifting toward anti-aging and multi-benefit products. So, P&G is adjusting its product pipeline to meet changing customer preferences. In addition to Olay, P&G said it is innovating in core brands like Pantene and Head and Shoulders, and saw 5% growth in P&G-owned Japanese luxury skincare brand, SK II. P&G attributed the strong performance of SK II to brand building and improved sentiment in China toward Japanese brands. P&G is applying strategies and processes that have worked in Europe and North America to China. For example, P&G's distributor channels that feed into wholesale markets and smaller grocery stores are now paid by category, not based on the total business. This means that distributors must deliver in each P&G category to be fully compensated. This gives the company better control from front-end innovation to customer discussions, which P&G said wasn't the case two years ago. P&G can't control the market cycle in China, but it is taking steps to improve its product pipeline and how it distributes and positions its products in front of customers. Since China is underperforming by such a wide margin relative to strong geographies like North America and Europe, it will have a big impact on P&G's full-year fiscal 2025 guidance. On the earnings call, P&G said it expects a recovery in the second half of its fiscal year (first half of calendar year 2025). However, China could single-handedly cause P&G to miss its organic sales growth forecast if P&G's progress in the region regresses. However, if China becomes even a neutral contributor to sales growth, P&G could hit the midpoint or slightly above its organic sales growth guidance. P&G is forecasting 10% to 12% diluted earnings per share (EPS) growth in fiscal 2025 compared to 2024, core EPS growth of 5% to 7%, and all-in sales of 2% to 4%. Volumes, pricing, foreign exchange, and the product mix within a given category impact all-in sales growth. Despite a strong U.S. dollar, P&G didn't have nearly the foreign exchange headwind in the second quarter as seen in the prior quarter or in fiscal 2024. However, investors should remain aware of the risks a strong dollar and potential tariffs impose on the business. P&G stock rose nearly 2% the day it reported earnings as investors cheered a return to volume growth and reaffirmed full fiscal year guidance. China also showed noticeable signs of improvement as P&G has done an impressive job changing its internal processes in the region to help offset slowing consumer spending. All told, China is still dragging down the stock, but not to the extent of prior quarters. P&G's recovery in the region is a testament to the strength of its brand portfolio, new product development, highly efficient supply chain, and marketing. The stock remains a solid buy for risk-averse investors looking to boost passive income generation for years to come. Investors can likely count on P&G to raise its dividend in April as it has done for decades. P&G has a yield of 2.4% compared to 1.2% for the S&P 500. And while you can find much higher-yielding stocks than P&G, there are only a handful of companies with a combination of industry leadership, recession resistance, and dividend reliability on par with P&G. Add it all up, and P&G is a stock to consider buying now. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $369,816!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $42,191!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $527,206!* Right now, we're issuing 'Double Down' alerts for three incredible companies, and there may not be another chance like this anytime soon.*Stock Advisor returns as of January 21, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Is China Dragging Down This Dow Jones Dividend King Stock? was originally published by The Motley Fool
